RT Journal Article
SR Electronic
T1 Differences of clinical and imaging findings in multiple generations of secondary COVID-19 infection in Xi’an, China
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.05.23.20109496
DO 10.1101/2020.05.23.20109496
A1 Li, Runqing
A1 Jian, Zhijie
A1 Jin, Chao
A1 Wang, Yan
A1 Liang, Ting
A1 Liu, Zhe
A1 Zhao, Huifang
A1 Wang, Zekun
A1 Zhou, Jie
A1 Zeng, Lingxia
A1 Yang, Jian
YR 2020
UL http://medrxiv.org/content/early/2020/05/25/2020.05.23.20109496.abstract
AB PURPOSE In the global presence of secondary infections with the coronavirus disease 2019 (COVID-19), little is known about the transmission characteristics of COVID-19 outside Wuhan, China. We evaluated differences in clinic and radiologic findings of multiple generations of COVID-19 infection in Xi’an (Shaanxi, China) to provide more clues for the correct estimate of the disease.METHODS All COVID-19 infected patients reported in Xi’an up to 10 February 2020 were included for this analysis. Among these cases, clinical and chest CT data of 62 cases were obtained from three hospital in Xi’an. With this information, patients were grouped on basis of exposure history and transmission chains as first-generation, second-generation and third-generation patients. We described clinical characteristics and evaluated CT score/patterns in these COVID-19 cases.RESULTS There was a clear age differences in multiple generations with COVID-19 infection. Above two thirds of the second-generation (75.0%) and third-generation patients (77.8%) were aged ≥45 years while 40.0% of first-generation cases at this age (p=0.001). More than half of second-generation patients (52.8%) and third-generation patients (55.6%) have comorbidities and is predominantly hypertensive (22.8% of second-generation vs. 27.8% of third-generation infections). The main exposure of second- and third-generation patients in Xi’an is family exposure (35.2%). For evaluation of CT findings of pulmonary involvement, the total CT score were 4.22±3.00 in first-generation group, 4.35±3.03 in second-generation group and 7.62±3.56 in third-generation group (p<0.001). In all of three generations, the predominant pattern of abnormality observed was organizing pneumonia (65.5% in first-generation group, 61.5% in second-generation group and 71.4% in third-generation group). The average courses of the disease in third-generation infections has obviously extension (22.93±7.22 days of first-generation, 21.53±8.31 days of second-generation vs. 31.00±8.12 days of third-generation group, p=0.004). There were no significant differences of the pulmonary sequelae among three generation patients.CONCLUSION There is more serious pulmonary infection of COVID-19 pneumonia in second- and third-generation patients, which might be attribute to the elder age and comorbidity of these patients.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was supported by "Xi'an Special Science and Technology Projects on Prevention and Treatment of Novel Coronavirus Pneumonia Emergency" (Grant Number: 20200005YX005).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by the institutional review board (Number: XJTU1AF2020LSK-011). Informed patients' consent was waived.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesSome or all data, models, or code generated or used during the study are available from the corresponding author by request.